Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

TYO/9267 stock hub

TYO/9267 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TYO/9267is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

110.9B

Tokyo Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TYO/9267

In the news

Latest news · TYO/9267

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.9

P25 12.7P50 15.8P75 21.7

Trailing P/E14.2

P25 11.7P50 15.2P75 22.3

ROE14.2

P25 -1.6P50 7.1P75 11.9

ROIC12.4

P25 -0.6P50 6.2P75 14.3

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TYO/9267 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

JPY

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	JP
Employees	1,841
Employees Change	180%
Employees Change Percent	10.84
Enterprise value	JPY 138.1B
Exchange	Tokyo Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	JP3282750003
Last refreshed	2026-05-10
Market cap	JPY 110.9B
Price	JPY 3,635
Price currency	JPY
Rev Per Employee	116,845,736.01x
Sector	Healthcare
Sic	5400
Symbol	tyo/9267
Website	https://www.genkydrugstores.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.05%
EV Earnings	17.67x
EV/EBIT	12.81x
EV/EBITDA	7.84x
EV/Sales	0.64x
Forward P/E	12.91x
P/B ratio	1.88x
P/E ratio	14.2x
P/S ratio	0.52x
PE Ratio10 Y	15.43x
PE Ratio3 Y	15.82x
PE Ratio5 Y	14.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	JPY 43.9B
Gross Profit Growth	10.49%
Gross Profit Growth Q	6.78%
Gross Profit Growth3 Y	9.26%
Gross Profit Growth5 Y	7.93%
Net Income	JPY 7.8B
Net Income Growth	15.92%
Net Income Growth Q	-0.25%
Net Income Growth Years	3%
Net Income Growth3 Y	18.74%
Net Income Growth5 Y	11.92%
Pretax Margin	5.12%
Profit Per Employee	JPY 4.2M
Profitable Years	21
ROA	5
Roa5y	4.51
ROCE	11.76
ROE	14.17
Roe5y	14.01
ROIC	12.36
Roic5y	8.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.86%
Cagr3y	21.31%
Cagr5y	16.66%
Div CAGR3	1.32%
Div CAGR5	-7.06%
EPS Growth	15.57
EPS Growth Q	-0.68
EPS Growth Years	3
EPS Growth3 Y	18.55
EPS Growth5 Y	11.81
Revenue Growth	9.94x
Revenue Growth Q	7.86x
Revenue Growth Quarters	50x
Revenue Growth Years	12x
Revenue Growth3 Y	9.23x
Revenue Growth5 Y	8.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	JPY 1.6
Assets	JPY 142.3B
Cash	JPY 11.4B
Current Assets	JPY 47.6B
Current Liabilities	JPY 50.6B
Debt	JPY 38.6B
Debt Equity	JPY 0.65
Equity	JPY 59.1B
Interest Coverage	39.49
Liabilities	JPY 83.3B
Long Term Assets	JPY 94.7B
Long Term Liabilities	JPY 32.6B
Net Cash	JPY -27.2B
Net Cash By Market Cap	JPY -24.55
Net Debt EBITDA	JPY 1.54
Net Debt Equity	JPY 0.46
Tangible Book Value	JPY 58.8B
Tangible Book Value Per Share	JPY 1,929
WACC	5.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.94
Inventory Turnover	6.5
Net Working Capital	JPY -4B
Quick ratio	0.34
Working Capital	JPY -3B
Working Capital Turnover	JPY -123

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.19%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	JPY 13
Dividend Years	10
Dividend Yield	0.36%
Ex Div Date	2026-06-18
Last Dividend	JPY 6.5
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.86%
200-day SMA	4,554.3
3Y total return	78.53%
50-day SMA	4,010.1
50-day SMA vs 200-day SMA	50under200
5Y total return	116.05%
All Time High	5,460
All Time High Change	-33.42%
All Time High Date	2025-10-31
All Time Low	713.5
All Time Low Change	409.46%
All Time Low Date	2020-03-13
ATR	124.7
Beta	0.49
Beta1y	0.38
Beta2y	0.51
Ch YTD	-26.71
High	3,680
High52	5,460
High52 Date	2025-10-31
High52ch	-33.42%
Low	3,585
Low52	3,370
Low52 Date	2025-06-05
Low52ch	7.86%
Ma50ch	-9.35%
Price vs 200-day SMA	-20.19%
RSI	35.58
RSI Monthly	48
RSI Weekly	36.78
Sharpe ratio	0.46x
Sortino ratio	0.91
Total Return	0.17%
Tr YTD	-26.71
Tr1m	-12.62%
Tr1w	3.27%
Tr3m	-18.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	JPY 10.8B
Operating Income Growth	15.17
Operating Income Growth Q	-1.47
Operating Income Growth3 Y	20
Operating Income Growth5 Y	10.5
Operating margin	5.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,581,129%
Shares Insiders	41.68%
Shares Institutions	23.5%
Shares Out	30,499,499
Shares Qo Q	-0.01%
Shares Yo Y	0.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	83,565x
Bv Per Share	1,937.3
Ch1m	-12.62
Ch1w	3.27
Ch1y	0.55
Ch3m	-18.86
Ch3y	76.24
Ch5y	110.4
Ch6m	-27.45
Change	0.55%
Change From Open	0.28
Close	3,615
Days Gap	0.28
Depreciation Amortization	6,836,500,000
Dollar Volume	334,783,500
Earnings Date	2026-04-28
EBIT	JPY 10.8B
EBITDA	JPY 17.6B
EPS	JPY 256
F Score	3
Fiscal Year End	June
Founded	1,988
Graham Number	3340.11639
Graham Upside	-8.11
Income Tax	JPY 3.2B
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-20
Last Split Date	2024-06-19
Last Split Type	Forward
Lynch Fair Value	JPY 3,052
Lynch Upside	-16.05
Ma150	4,555.8
Ma150ch	-20.21%
Ma20	3,949.5
Ma20ch	-7.96%
Next Earnings Date	2026-07-27
Open	3,625
Payment Date	2026-09-14
Position In Range	52.63
Ppne	87,253,000,000
Price Date	2026-05-08
Price EBITDA	JPY 6.29
Ptbv Ratio	1.88
Relative Volume	1.14x
Revenue	215,113,000,000x
Tax By Revenue	1.49x
Tr6m	-27.35%
Volume	92,100

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TYO/9267 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$13.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-7.1%

0 consecutive years of growth

Total shareholder yield

+0.2%

Next ex-dividend date: 2026-06-18

Performance

TYO/9267 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TYO/9267?

Insider, institutional, and short-interest positioning.

Institutional ownership

+23.5%

Share of float held by funds and institutions

Insider ownership

+41.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

TYO/9267 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.6

Neutral momentum band

Price vs 200-day MA

-20.2%

50/200-day relationship not available

Beta (5Y)

0.49

Less volatile than the market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TYO/9267

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/9267 stock rating?

tyo/9267 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/9267 analysis?

The full report lives at /stocks/tyo/9267/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/9267?

The latest report frames tyo/9267 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/9267 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.